FMA
PGNX

FNY Managed Accounts’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

FNY Managed Accounts’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Hold
0
– – – 906
2017
Q4 		– Hold
0
– – – 877
2017
Q3 		– Hold
0
– – – 693
2015
Q3 		– Hold
0
– – – 514
2015
Q2 		– Sell
-42,000
Closed -$251K – 493
2015
Q1 		$251K Buy
+42,000
New +$251K 0.21% 65